Prime Highlights
- Dhaval Shah becomes Acting CEO with immediate effect.
- Shyam Karunakaran takes charge as President.
Key Facts
- CitiusTech provides technology services to the healthcare industry.
- Rajan Kohli will leave the CEO role by the end of August 2026.
Background
Healthcare technology company CitiusTech has elevated Dhaval Shah to Acting Chief Executive Officer and Shyam Karunakaran to President as part of a leadership transition. The changes take effect immediately.
Rajan Kohli, the company’s current CEO, will leave his role by the end of August 2026 to pursue other opportunities. The company said Shah and Karunakaran will lead its next phase of growth and strengthen its focus on healthcare technology and business expansion.
Shah, who has spent more than 19 years at CitiusTech, previously served as Chief Business Officer for the MedTech and Life Sciences businesses. He helped build these businesses and has played a key role in shaping the company’s culture and operating model.
As Acting CEO, Shah will focus on advancing CitiusTech’s strategy and expanding its healthcare intelligence capabilities. He said the company aims to make intelligence a key part of how healthcare organisations operate, make decisions and improve outcomes.
Karunakaran has spent 17 years with CitiusTech and previously led its Healthcare Payer and Platforms businesses. As President, he will oversee enterprise strategy, markets, growth and execution across the wider organisation.
CitiusTech Chairman Dr William Winkenwerder Jr. said Shah and Karunakaran bring strong knowledge of the company, its clients and the healthcare industry. He added that their combined experience and leadership record position them well to guide the company through its next growth phase.
Kohli said he was proud of the company’s progress during his tenure and highlighted its partnerships, client relationships and technology capabilities. He expressed confidence in Shah and Karunakaran as they take the company forward.
